Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Florida’s insurance market is under intense pressure as millions of residents and trillions in property wealth cluster along hurricane‑vulnerable coastlines. This article breaks down how decades of growth in high‑risk zones created today’s crisis, why traditional pricing models can’t keep up, and what real estate and insurance professionals must do to stay ahead. It offers actionable insights on underwriting, risk communication, policy partnerships, and resilience planning—critical knowledge for anyone advising Florida homeowners or navigating the state’s evolving insurance landscape.
Florida’s homeowners insurance market may have stabilized, but not in the way residents hoped. After years of runaway increases, premiums have stopped spiking—but they’re holding at painfully high levels. Coastal properties remain the hardest hit, with some policies topping $15,000 a year, while insurers continue demanding costly upgrades and resisting calls for transparency. For real estate professionals, understanding these pricing pressures is becoming essential as insurance costs increasingly shape buyer decisions across the state.
Florida homeowners face soaring premiums, shrinking insurer options, and storms that grow stronger each year. This article breaks down what hurricane insurance actually covers, how deductibles really work, why flood insurance is essential, and what professionals in real estate, mortgage, and insurance must understand to protect clients and properties before the next major storm hits.
Teresa King Kinney, one of the most influential executives in modern real estate, is retiring after 33 years as CEO of the MIAMI Association of Realtors. Under her leadership, the organization grew from 5,000 members to 60,000, became a global real estate powerhouse, and built the nation’s largest association‑owned MLS. As she transitions into CEO Emeritus, MIAMI prepares for a new era shaped by the foundation she spent decades building.
Miami’s commercial property market is heating up again, posting an 11% jump in investment volume for 2025. The surge is driven largely by a revitalized retail sector fueled by population growth, strong tourism, and new mixed‑use development. While office and industrial activity remains steady but softer, investor confidence is returning as Miami’s CRE landscape matures and buyers re‑enter the market with renewed interest in high‑traffic retail opportunities.
The Federal Reserve is preparing major changes to mortgage regulations in an effort to pull more mortgage activity back into the banking sector. With banks losing significant market share to nonbank lenders over the past decade, Fed Vice Chair for Supervision Michelle Bowman says new proposals may ease capital requirements and make mortgage servicing more attractive for banks. These shifts could have wide‑ranging effects on real estate professionals, lenders, and borrowers as the balance of power in the mortgage market begins to shift once again.
